Legal & General Group
PDSB icon

Legal & General Group’s PDS Biotechnology PDSB Stock Holding History

Legal & General Group’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,988
Closed -$11.8K – 3483
2024
Q1 		$11.8K Hold
2,988
– – ﹤0.01% 3169
2023
Q4 		$14.8K Sell
2,988
-393
-12% -$1.95K ﹤0.01% 3144
2023
Q3 		$17.1K Hold
3,381
– – ﹤0.01% 3099
2023
Q2 		$17K Buy
+3,381
New +$22.1K ﹤0.01% 3180
2018
Q2 		– Sell
-168
Closed -$4K – 3375
2018
Q1 		$4K Sell
168
-108
-39% -$29K ﹤0.01% 3261
2017
Q4 		$52K Hold
276
– – ﹤0.01% 2849
2017
Q3 		$60K Buy
276
+73
+36% +$15.1K ﹤0.01% 2853
2017
Q2 		$42K Hold
203
– – ﹤0.01% 2954
2017
Q1 		$37K Sell
203
-4
-2% -$792 ﹤0.01% 2926
2016
Q4 		$51K Buy
207
+55
+36% +$12.5K ﹤0.01% 2886
2016
Q3 		$32K Hold
152
– – ﹤0.01% 2715
2016
Q2 		$29K Buy
+152
New +$26.9K ﹤0.01% 2752

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Legal & General Group's PDSB Position: Q2 2024 in Review

Legal & General Group sold out of PDS Biotechnology (PDSB) in Q2 2024, closing a stake of 2,988 shares — an estimated $11.8K sold.

Legal & General Group first reported a position in PDSB in Q2 2016 and held it in 12 quarters. The position peaked at $60K in Q3 2017. 77 funds tracked by Wall St. Rank hold PDSB as of Q2 2024.

  • Legal & General Group reported no remaining PDS Biotechnology position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 2,988 PDS Biotechnology shares in Q2 2024, an estimated $11.8K.
  • Legal & General Group first reported a position in PDS Biotechnology in Q2 2016 and held it in 12 quarters.
  • Legal & General Group's PDS Biotechnology position peaked at $60K in Q3 2017.
  • 77 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.